Product category:
Polymerase chain reaction (PCR)
News Release from: Applied Biosystems | Subject: Gene Signature Panels
Edited by the Laboratorytalk Editorial
Team on 14 February 2006
Simplify drug discovery with gene
signature panels
The new arrays include the Human G protein-coupled receptors (GPCR) panel, Human protein kinase panel, Mouse immune panel, and Human endogenous controls panel
Applied Biosystems has introduced four new gene signature panels as part of its TaqMan low density array (TLDA) product line for real-time PCR applications The Applied Biosystems TaqMan low density arrays are 384-well micro fluidic cards designed for analysing gene expression patterns in many samples across a defined set of gene targets
This article was originally published on Laboratorytalk on 25 Jan 2007 at 8.00am (UK)
Related stories
Gene signature panels speed up drug discovery
TaqMan low density array gene signature panels aim to accelerate drug discovery research by determining the expression levels of genes encoding proteins involved with critical cellular functions
The arrays use gold standard TaqMan chemistry for quantitative gene expression and combine the accuracy, sensitivity and high reproducibility of real-time PCR with the convenience of pre-configured panels for target screening and disease association research.
The arrays also streamline reaction set-up, reduce reagent consumption and require no liquid-handling robotics.
The new gene signature panels are available off-the-shelf and in smaller quantities, and Applied Biosystems also offers custom TaqMan low density arrays, allowing researchers to design their own assay panels by choosing genes of interest from more than 40,000 inventoried TaqMan gene expression assays.
• Applied Biosystems: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
